RFA
ICPT

Reilly Financial Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Reilly Financial Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10
Closed -$2K – 919
2016
Q3 		$2K Hold
10
– – ﹤0.01% 768
2016
Q2 		$1K Hold
10
– – ﹤0.01% 781
2016
Q1 		$1K Buy
+10
New +$1.18K ﹤0.01% 1141
2015
Q4 		– Sell
-31
Closed -$5K – 1413
2015
Q3 		$5K Buy
+31
New +$6.82K ﹤0.01% 971

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Reilly Financial Advisors's ICPT Position: Q4 2016 in Review

Reilly Financial Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2016, closing a stake of 10 shares — an estimated $2K sold.

Reilly Financial Advisors first reported a position in ICPT in Q3 2015 and held it in 4 quarters. The position peaked at $5K in Q3 2015. 159 funds tracked by Wall St. Rank hold ICPT as of Q4 2016.

  • Reilly Financial Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Reilly Financial Advisors sold 10 Intercept Pharmaceuticals, Inc. shares in Q4 2016, an estimated $2K.
  • Reilly Financial Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2015 and held it in 4 quarters.
  • Reilly Financial Advisors's Intercept Pharmaceuticals, Inc. position peaked at $5K in Q3 2015.
  • 159 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2016.

Based on Reilly Financial Advisors's 13F filing for Q4 2016, filed 24 Jan 2017.